Item Type | Name |
Academic Article
|
Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma.
|
Academic Article
|
Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma.
|
Academic Article
|
Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international population.
|
Concept
|
Kidney Failure, Chronic
|
Concept
|
Kidney
|
Concept
|
Kidney Neoplasms
|
Concept
|
Kidney Pelvis
|
Concept
|
Kidney Function Tests
|
Academic Article
|
Intraoperative sonography during open partial nephrectomy for renal cell cancer: does it alter surgical management?
|
Academic Article
|
Does retroperitoneal lymphadenectomy for testicular germ cell tumor require a different approach in the presence of horseshoe kidney?
|
Academic Article
|
The role of cytoreductive nephrectomy in the management of metastatic renal cell carcinoma.
|
Academic Article
|
Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression.
|
Academic Article
|
Treatment of patients with metastatic renal cell cancer: a RAND Appropriateness Panel.
|
Academic Article
|
Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?
|
Academic Article
|
Renal cell carcinoma clinically involving adjacent organs: experience with aggressive surgical management.
|
Academic Article
|
Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experience.
|
Academic Article
|
Risk assessment of renal cell carcinoma using alkaline comet assay.
|
Academic Article
|
Renal cell carcinoma: diagnosis, staging, and surveillance.
|
Academic Article
|
Randomized trial of adjuvant thalidomide versus observation in patients with completely resected high-risk renal cell carcinoma.
|
Academic Article
|
Pre-surgical targeted molecular therapy in renal cell carcinoma.
|
Academic Article
|
Sensitivity to NNKOAc is associated with renal cancer risk.
|
Academic Article
|
Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
|
Academic Article
|
Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease.
|
Academic Article
|
Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.
|
Academic Article
|
Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract.
|
Academic Article
|
Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy?
|
Academic Article
|
Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract.
|
Academic Article
|
Development and characterization of clinically relevant tumor models from patients with renal cell carcinoma.
|
Academic Article
|
Role of inflammatory related gene expression in clear cell renal cell carcinoma development and clinical outcomes.
|
Academic Article
|
Kinome expression profiling identifies IKBKE as a predictor of overall survival in clear cell renal cell carcinoma patients.
|
Academic Article
|
Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification.
|
Academic Article
|
Re: Illness uncertainty and quality of life of patients with small renal tumors undergoing watchful waiting: a 2-year prospective study.
|
Academic Article
|
Joint association of genome-wide association study-identified susceptibility loci and dietary patterns in risk of renal cell carcinoma among non-Hispanic whites.
|
Academic Article
|
Spontaneous regression of pulmonary metastases from renal cell carcinoma after radio frequency ablation of primary tumor: an in situ tumor vaccine?
|
Academic Article
|
Young age is an independent prognostic factor for survival of sporadic renal cell carcinoma.
|
Academic Article
|
A renal mass in the setting of a nonrenal malignancy: When is a renal tumor biopsy appropriate?
|
Academic Article
|
Evaluation of the intact specimen after laparoscopic radical nephrectomy for clinically localized renal cell carcinoma identifies a subset of patients at increased risk for recurrence.
|
Academic Article
|
Adjuvant therapy for renal cell carcinoma.
|
Academic Article
|
Conventional and hand-assisted laparoscopic radical nephrectomy: Comparative analysis of 271 cases.
|
Academic Article
|
Multimodal approaches in the management of locally advanced and metastatic renal cell carcinoma: combining surgery and systemic therapies to improve patient outcome.
|
Academic Article
|
Cytoreductive nephrectomy in the elderly patient: the M. D. Anderson Cancer Center experience.
|
Academic Article
|
Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma.
|
Academic Article
|
Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
|
Academic Article
|
Contemporary strategies for treating nonhereditary synchronous bilateral renal tumors and the impact of minimally invasive, nephron-sparing techniques.
|
Academic Article
|
Genetic susceptibility to renal cell carcinoma: the role of DNA double-strand break repair pathway.
|
Academic Article
|
Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study.
|
Academic Article
|
Neoadjuvant (presurgical) therapy for renal cell carcinoma: a new treatment paradigm for locally advanced and metastatic disease.
|
Academic Article
|
The role of lymphadenectomy in renal cell carcinoma.
|
Academic Article
|
Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma.
|
Academic Article
|
Identifying the risk of disease progression after surgery for localized renal cell carcinoma.
|
Academic Article
|
Genetic variations in microRNA-related genes are associated with survival and recurrence in patients with renal cell carcinoma.
|
Academic Article
|
Integrating surgery with targeted therapies for renal cell carcinoma: current evidence and ongoing trials.
|
Academic Article
|
Radio frequency ablation of renal tumors in patients with metastatic renal cell carcinoma.
|
Academic Article
|
The dark side of targeted therapy.
|
Academic Article
|
The RENAL nephrometry nomogram: statistically significant, but is it clinically relevant?
|
Academic Article
|
The role of lymph node dissection in renal cell carcinoma.
|
Academic Article
|
Renal cell carcinoma: what the surgeon and treating physician need to know.
|
Academic Article
|
Early primary tumor size reduction is an independent predictor of improved overall survival in metastatic renal cell carcinoma patients treated with sunitinib.
|
Academic Article
|
Adjuvant and neoadjuvant therapy for renal cell carcinoma: a survey of the Society of Urologic Oncology.
|
Academic Article
|
Environmental and modifiable risk factors in renal cell carcinoma.
|
Academic Article
|
The effects of temporary ischemia in partial nephrectomy on renal functional outcomes: how can effects best be estimated, and can they be mitigated?
|
Academic Article
|
Integration of surgery and systemic therapy for renal cell carcinoma.
|
Academic Article
|
Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases.
|
Academic Article
|
Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy.
|
Academic Article
|
Novel agents and approaches for advanced renal cell carcinoma.
|
Academic Article
|
Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma.
|
Academic Article
|
Real-time magnetic resonance imaging-guided cryoablation of small renal tumors at 1.5 T.
|
Academic Article
|
Cytoreductive nephrectomy for metastatic renal cell carcinoma.
|
Academic Article
|
Autotaxin-lysophosphatidic acid signaling axis mediates tumorigenesis and development of acquired resistance to sunitinib in renal cell carcinoma.
|
Academic Article
|
Biomarkers of renal cell carcinoma.
|
Academic Article
|
Role of metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy.
|
Academic Article
|
Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study.
|
Academic Article
|
Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes.
|
Academic Article
|
Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome.
|
Academic Article
|
Lymphocyte activation antigen CD70 expressed by renal cell carcinoma is a potential therapeutic target for anti-CD70 antibody-drug conjugates.
|
Academic Article
|
Staging refinements in renal cell carcinoma.
|
Academic Article
|
Molecular markers of prognosis in renal cell carcinoma: Insight into tumor biology helps define risk and provides targets for therapy.
|
Academic Article
|
Laparoscopic cytoreductive nephrectomy: the M. D. Anderson Cancer Center experience.
|
Academic Article
|
Redefining pT3 renal cell carcinoma in the modern era: a proposal for a revision of the current TNM primary tumor classification system.
|
Academic Article
|
Telomere dysfunction in peripheral lymphocytes as a potential predisposition factor for renal cancer.
|
Academic Article
|
Cytoreductive nephrectomy for metastatic renal cell carcinoma with nonclear cell histology.
|
Academic Article
|
Adjuvant approaches to renal cell carcinoma.
|
Academic Article
|
Patterns of intervention for renal lesions in von Hippel-Lindau disease.
|
Academic Article
|
Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma.
|
Academic Article
|
An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial.
|
Academic Article
|
Cytoreductive nephrectomy in metastatic renal cell carcinoma.
|
Academic Article
|
Case-control analysis of nucleotide excision repair pathway and the risk of renal cell carcinoma.
|
Academic Article
|
Current status of debulking nephrectomy in the era of tyrosine kinase inhibitors.
|
Academic Article
|
Single nucleotide polymorphisms of microRNA machinery genes modify the risk of renal cell carcinoma.
|
Academic Article
|
Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma.
|
Academic Article
|
Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
|
Academic Article
|
Innovations and challenges in renal cancer: summary statement from the Third Cambridge Conference.
|
Academic Article
|
Cytoreductive nephrectomy for metastatic RCC in the era of targeted therapy.
|
Academic Article
|
The extent of lymphadenectomy seems to be associated with better survival in patients with nonmetastatic upper-tract urothelial carcinoma: how many lymph nodes should be removed?
|
Academic Article
|
Role of cytoreductive nephrectomy in renal cell carcinoma.
|
Academic Article
|
Predictors of unilateral renal function after open and laparoscopic partial nephrectomy.
|
Academic Article
|
Editorial comment.
|
Academic Article
|
Early results of chemotherapy with retroperitoneal lymph node dissection for isolated retroperitoneal recurrence of upper urinary tract urothelial carcinoma after nephroureterectomy.
|
Academic Article
|
Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3.
|
Academic Article
|
The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus.
|
Academic Article
|
Safety of presurgical targeted therapy in the setting of metastatic renal cell carcinoma.
|
Academic Article
|
The role of surgery in advanced renal cell carcinoma: cytoreductive nephrectomy and metastasectomy.
|
Academic Article
|
Can a durable disease-free survival be achieved with surgical resection in patients with pathological node positive renal cell carcinoma?
|
Academic Article
|
The role of lymph node dissection in renal cell carcinoma.
|
Academic Article
|
Management of small renal masses: watch, cut, freeze, or fry?
|
Academic Article
|
Metastatic extraosseous Ewing's sarcoma (EES)/primitive neuroectodermal tumor (PNET) of the kidney: 8-year durable response after induction and maintenance chemotherapy.
|
Academic Article
|
A phase 2 trial of sunitinib in patients with advanced non-clear cell renal cell carcinoma.
|
Academic Article
|
Prediction of cancer specific survival after radical nephroureterectomy for upper tract urothelial carcinoma: development of an optimized postoperative nomogram using decision curve analysis.
|
Academic Article
|
Energy balance, polymorphisms in the mTOR pathway, and renal cell carcinoma risk.
|
Academic Article
|
Preoperative pulmonary embolism does not predict poor postoperative outcomes in patients with renal cell carcinoma and venous thrombus.
|
Academic Article
|
Neoadjuvant chemotherapy improves survival of patients with upper tract urothelial carcinoma.
|
Academic Article
|
Oncologic outcomes following surgical resection of renal cell carcinoma with inferior vena caval thrombus extending above the hepatic veins: a contemporary multicenter cohort.
|
Academic Article
|
Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience.
|
Academic Article
|
Update on staging controversies for locally advanced renal cell carcinoma.
|
Academic Article
|
Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.
|
Academic Article
|
Cytoreductive nephrectomy in the era of targeted molecular agents: is it time to consider presurgical systemic therapy?
|
Academic Article
|
BPDE induced lymphocytic chromosome 3p deletions may predict renal cell carcinoma risk.
|
Academic Article
|
Is patient performance status always an accurate surrogate for predicting tumor biology in patients with metastatic renal cancer?
|
Academic Article
|
Potent anticarcinoma activity of the humanized anti-CD70 antibody h1F6 conjugated to the tubulin inhibitor auristatin via an uncleavable linker.
|
Academic Article
|
The role of lymph node dissection in renal cell carcinoma: the pendulum swings back.
|
Academic Article
|
Family history and risk of renal cell carcinoma: results from a case-control study and systematic meta-analysis.
|
Academic Article
|
Prospective assessment of systemic therapy followed by surgical removal of metastases in selected patients with renal cell carcinoma.
|
Academic Article
|
Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy.
|
Academic Article
|
Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer.
|
Academic Article
|
Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: comparison with nephrectomy assessment.
|
Academic Article
|
International consultation on urologic diseases and the European Association of Urology international consultation on locally advanced renal cell carcinoma.
|
Academic Article
|
Oncological outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: comparison over the three decades.
|
Academic Article
|
Illness uncertainty and quality of life of patients with small renal tumors undergoing watchful waiting: a 2-year prospective study.
|
Academic Article
|
Radiofrequency ablation of renal tumours with clinical, radiographical and pathological results.
|
Academic Article
|
Robotic partial nephrectomy shortens warm ischemia time, reducing suturing time kinetics even for an experienced laparoscopic surgeon: a comparative analysis.
|
Academic Article
|
Is radiofrequency ablation safe for solitary kidneys?
|
Academic Article
|
Analysis of clinicopathologic predictors of oncologic outcome provides insight into the natural history of surgically managed papillary renal cell carcinoma.
|
Academic Article
|
Type III transforming growth factor-beta (TGF-beta) receptor mediates apoptosis in renal cell carcinoma independent of the canonical TGF-beta signaling pathway.
|
Academic Article
|
Sunitinib-induced acute hemolysis without hypertension: a case report.
|
Academic Article
|
Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration.
|
Academic Article
|
Primary tumor response to targeted agents in patients with metastatic renal cell carcinoma.
|
Academic Article
|
Racial differences in the outcome of patients with urothelial carcinoma of the upper urinary tract: an international study.
|
Academic Article
|
A genome-wide association study identifies a novel susceptibility locus for renal cell carcinoma on 12p11.23.
|
Academic Article
|
Comprehensive assessment of quality of life and psychosocial adjustment in patients with renal tumors undergoing open, laparoscopic and nephron sparing surgery.
|
Academic Article
|
MicroRNA target site polymorphisms in the VHL-HIF1a pathway predict renal cell carcinoma risk.
|
Academic Article
|
Positive vascular wall margins have minimal impact on cancer outcomes in patients with non-metastatic renal cell carcinoma (RCC) with tumour thrombus.
|
Academic Article
|
Perioperative outcomes following surgical resection of renal cell carcinoma with inferior vena cava thrombus extending above the hepatic veins: a contemporary multicenter experience.
|
Academic Article
|
Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma.
|
Academic Article
|
Partial nephrectomy in the setting of metastatic renal cell carcinoma.
|
Academic Article
|
Phase 2 trial of neoadjuvant axitinib in patients with locally advanced nonmetastatic clear cell renal cell carcinoma.
|
Academic Article
|
Salvage surgery after energy ablation for renal masses.
|
Academic Article
|
Population-based analysis of factors associated with survival in patients undergoing cytoreductive nephrectomy in the targeted therapy era.
|
Academic Article
|
Lymphatic drainage in renal cell carcinoma: back to the basics.
|
Academic Article
|
Treating the two extremes in renal cell carcinoma: management of small renal masses and cytoreductive nephrectomy in metastatic disease.
|
Academic Article
|
Next-generation sequencing of translocation renal cell carcinoma reveals novel RNA splicing partners and frequent mutations of chromatin-remodeling genes.
|
Academic Article
|
Neuroendocrine tumors of the kidney: a single institution experience.
|
Academic Article
|
Preoperative predictors of pathological lymph node metastasis in patients with renal cell carcinoma undergoing retroperitoneal lymph node dissection.
|
Academic Article
|
Mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney: a detailed study of radiological, pathological and clinical outcomes.
|
Academic Article
|
Multi-institutional validation of the predictive value of Ki-67 in patients with high grade urothelial carcinoma of the upper urinary tract.
|
Academic Article
|
Reporting geographic and temporal trends in renal cell carcinoma: why is this important?
|
Academic Article
|
Mitochondrial DNA copy number in peripheral blood leukocytes and the risk of clear cell renal cell carcinoma.
|
Academic Article
|
Role of partial nephrectomy as cytoreduction in the management of metastatic renal cell carcinoma.
|
Academic Article
|
Clinically nonmetastatic renal cell carcinoma with sarcomatoid dedifferentiation: Natural history and outcomes after surgical resection with curative intent.
|
Academic Article
|
Surgical Management of Local Retroperitoneal Recurrence of Renal Cell Carcinoma after Radical Nephrectomy.
|
Academic Article
|
Multilevel-analysis identify a cis-expression quantitative trait locus associated with risk of renal cell carcinoma.
|
Academic Article
|
Effects of Adjuvant Sorafenib and Sunitinib on Cardiac Function in Renal Cell Carcinoma Patients without Overt Metastases: Results from ASSURE, ECOG 2805.
|
Academic Article
|
Preoperative multivariable prognostic models for prediction of survival and major complications following surgical resection of renal cell carcinoma with suprahepatic caval tumor thrombus.
|
Academic Article
|
Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation.
|
Academic Article
|
Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapy.
|
Academic Article
|
Role of metastasectomy in metastatic renal cell carcinoma.
|
Academic Article
|
Prediction of Pulmonary Metastasis in Renal Cell Carcinoma Patients with Indeterminate Pulmonary Nodules.
|
Academic Article
|
Gene-environment interaction of genome-wide association study-identified susceptibility loci and meat-cooking mutagens in the etiology of renal cell carcinoma.
|
Academic Article
|
DNA Methylation Signature Reveals Cell Ontogeny of Renal Cell Carcinomas.
|
Academic Article
|
Outcomes of Adults With Ewing Sarcoma Family of Tumors (ESFT) of the Kidney
|
Academic Article
|
Mucinous tubular and spindle cell carcinoma (MTSCC) of the kidney
|
Academic Article
|
Metastases to the kidney
|
Academic Article
|
Kidney cancer
|
Academic Article
|
Renal Medullary Carcinoma: Establishing Standards in Practice.
|
Academic Article
|
BIGH3 Promotes Osteolytic Lesions in Renal Cell Carcinoma Bone Metastasis by Inhibiting Osteoblast Differentiation.
|
Academic Article
|
Outcomes of Adults With Ewing Sarcoma Family of Tumors (ESFT) of the Kidney: A Single-Institution Experience.
|
Academic Article
|
Metastases to the kidney: a comprehensive analysis of 151 patients from a tertiary referral centre.
|
Academic Article
|
Risk factors for recurrence after surgery in non-metastatic RCC with thrombus: a contemporary multicentre analysis.
|
Academic Article
|
Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases.
|
Academic Article
|
Variability of inter-observer agreement on feasibility of partial nephrectomy before and after neoadjuvant axitinib for locally advanced renal cell carcinoma (RCC): independent analysis from a phase II trial.
|
Academic Article
|
Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial.
|
Academic Article
|
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial.
|
Academic Article
|
Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations.
|
Academic Article
|
Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent.
|
Academic Article
|
Genomic DNA Hypomethylation and Risk of Renal Cell Carcinoma: A Case-Control Study.
|
Academic Article
|
Prognosticators and outcomes of patients with renal cell carcinoma and adjacent organ invasion treated with radical nephrectomy.
|
Academic Article
|
The Role of Metastasectomy in Patients with Renal Cell Carcinoma with Sarcomatoid Dedifferentiation: A Matched Controlled Analysis.
|
Academic Article
|
Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy.
|
Academic Article
|
Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study.
|
Academic Article
|
HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC).
|
Academic Article
|
Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma.
|
Academic Article
|
Cytoreductive Nephrectomy for Renal Cell Carcinoma with Venous Tumor Thrombus.
|
Academic Article
|
Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study.
|
Academic Article
|
Cytoreductive nephrectomy for metastatic renal cell carcinoma.
|
Academic Article
|
Study of the Kidney Tumor-Parenchymal Interface after Neoadjuvant Treatment with Axitinib for Locally Advanced Clear Cell Renal Cell Carcinoma: Matched Analysis from a Phase II Trial.
|
Academic Article
|
Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study.
|
Academic Article
|
Outcomes of Patients With Metastatic Renal Cell Carcinoma and Bone Metastases in the Targeted Therapy Era.
|
Academic Article
|
Editorial Comment.
|
Academic Article
|
Prognostic significance of promoter CpG island methylation of obesity-related genes in patients with nonmetastatic renal cell carcinoma.
|
Academic Article
|
Prognostic Value of PD-1 and PD-L1 Expression in Patients with High Grade Upper Tract Urothelial Carcinoma.
|
Academic Article
|
Retroperitoneal Lymphadenectomy for High Risk, Nonmetastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG-ACRIN 2805) Adjuvant Trial.
|
Academic Article
|
Induction and Maintenance Adjuvant Mitomycin C Topical Therapy for Upper Tract Urothelial Carcinoma: Tolerability and Intermediate Term Outcomes.
|
Academic Article
|
Predictive Nomogram for Recurrence following Surgery for Nonmetastatic Renal Cell Cancer with Tumor Thrombus.
|
Academic Article
|
Outcomes of Patients with Renal Cell Carcinoma and Sarcomatoid Dedifferentiation Treated with Nephrectomy and Systemic Therapies: Comparison between the Cytokine and Targeted Therapy Eras.
|
Academic Article
|
Potential Susceptibility Loci Identified for Renal Cell Carcinoma by Targeting Obesity-Related Genes.
|
Academic Article
|
Adjuvant chemotherapy after radical nephroureterectomy does not improve survival in patients with upper tract urothelial carcinoma: a joint study by the European Association of Urology-Young Academic Urologists and the?Upper Tract Urothelial Carcinoma Collaboration.
|
Academic Article
|
Local Tumor Bed Recurrence Following Partial Nephrectomy in Patients with Small Renal Masses.
|
Academic Article
|
Energy stress-induced lncRNA FILNC1 represses c-Myc-mediated energy metabolism and inhibits renal tumor development.
|
Academic Article
|
Pathologic Predictors of Survival During Lymph Node Dissection for Metastatic Renal-Cell Carcinoma: Results From a Multicenter Collaboration.
|
Academic Article
|
The Effects of Neoadjuvant Axitinib on Anthropometric Parameters in Patients With Locally Advanced Non-metastatic Renal Cell Carcinoma.
|
Academic Article
|
Frequency and Prognostic Value of PTEN Loss in Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.
|
Academic Article
|
Programmed cell death ligand 1 and tumor-infiltrating lymphocyte status in patients with renal cell carcinoma and sarcomatoid dedifferentiation.
|
Academic Article
|
Intraoperative Conversion From Partial to Radical Nephrectomy: Incidence, Predictive Factors, and Outcomes.
|
Academic Article
|
Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.
|
Academic Article
|
Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome.
|
Academic Article
|
Conditional survival of patients with small renal masses undergoing active surveillance.
|
Academic Article
|
The Value of Neutrophil to Lymphocyte Ratio in Patients Undergoing Cytoreductive Nephrectomy with Thrombectomy.
|
Academic Article
|
Renal cell carcinoma and pathologic nodal disease: Implications for American Joint Committee on Cancer staging.
|
Academic Article
|
Global and Targeted miRNA Expression Profiling in Clear Cell Renal Cell Carcinoma Tissues Potentially Links miR-155-5p and miR-210-3p to both Tumorigenesis and Recurrence.
|
Academic Article
|
Surgical Complications of Presurgical Systemic Therapy for Renal Cell Carcinoma: A Systematic Review.
|
Academic Article
|
Adjuvant therapy for advanced renal cell carcinoma.
|
Academic Article
|
Prognostic significance of BAP1 expression in high-grade upper tract urothelial carcinoma: a multi-institutional study.
|
Academic Article
|
Salvage topical therapy for upper tract urothelial carcinoma.
|
Academic Article
|
Surgical Metastasectomy in Renal Cell Carcinoma: A Systematic Review.
|
Academic Article
|
Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation.
|
Academic Article
|
Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma.
|
Academic Article
|
Temsirolimus versus Pazopanib (TemPa) in Patients with Advanced Clear-cell Renal Cell Carcinoma and Poor-risk Features: A Randomized Phase II Trial.
|
Academic Article
|
Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial.
|
Academic Article
|
Predicting Adherent Perinephric Fat Using Preoperative Clinical and Radiological Factors in Patients Undergoing Partial Nephrectomy.
|
Academic Article
|
PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy.
|
Academic Article
|
The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC).
|
Academic Article
|
EDITORIAL COMMENT.
|
Academic Article
|
Results of the ADAPT Phase 3 Study of Rocapuldencel-T in Combination with Sunitinib as First-Line Therapy in Patients with Metastatic Renal Cell Carcinoma.
|
Academic Article
|
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma.
|
Academic Article
|
Summary From the First Kidney Cancer Research Summit, September 12-13, 2019: A Focus on Translational Research.
|
Academic Article
|
Stereotactic Body Radiation Therapy for the Definitive Treatment of Early Stage Kidney Cancer: A Survival Comparison With Surgery, Tumor Ablation, and Observation.
|
Academic Article
|
Macrophage HIF-1a Is an Independent Prognostic Indicator in Kidney Cancer.
|
Academic Article
|
Neoadjuvant Therapy for Locally Advanced Renal Cell Carcinoma.
|
Academic Article
|
Survival following cytoreductive nephrectomy: a comparison of existing prognostic models.
|
Academic Article
|
Cytoreductive Nephrectomy in Patients Presenting With Advanced Disease: Have We Finally Answered the Question?
|
Academic Article
|
Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinoma.
|
Academic Article
|
Outcomes of patients with metastatic renal cell carcinoma with sarcomatoid dedifferentiation to immune checkpoint inhibitors.
|
Academic Article
|
Summary from the Kidney Cancer Association's Inaugural Think Thank: Coalition for a Cure.
|
Academic Article
|
Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma.
|
Academic Article
|
Safe and effective use of nivolumab plus ipilimumab in a patient with metastatic clear-cell renal cell carcinoma with sarcomatoid dedifferentiation and end stage renal disease on hemodialysis.
|
Academic Article
|
Prolyl Hydroxylase 3 Knockdown Accelerates VHL-Mutant Kidney Cancer Growth In Vivo.
|
Academic Article
|
Outcomes of Percutaneous Thermal Ablation for Biopsy-Proven T1a Renal Cell Carcinoma in Patients With Other Primary Malignancies.
|
Academic Article
|
Correction: Macrophage HIF-1a Is an Independent Prognostic Indicator in Kidney Cancer.
|
Academic Article
|
Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation.
|
Academic Article
|
Sarcomatoid features and lymph node-positive disease in chromophobe renal cell carcinoma.
|
Academic Article
|
Adjuvant therapy in patients with sarcomatoid renal cell carcinoma: post hoc analysis from Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) E2805.
|
Academic Article
|
Efficacy and safety of gemcitabine plus doxorubicin in patients with renal medullary carcinoma.
|
Academic Article
|
Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma.
|
Academic Article
|
PET/MR Imaging of a Lung Metastasis Model of Clear Cell Renal Cell Carcinoma with (2S,4R)-4-[18F]Fluoroglutamine.
|
Academic Article
|
Cytoreductive Nephrectomy for Patients with Metastatic Sarcomatoid and/or Rhabdoid Renal Cell Carcinoma Treated with Immune Checkpoint Therapy.
|
Academic Article
|
Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma.
|
Academic Article
|
Contemporary Patients Have Better Perioperative Outcomes Following Cytoreductive Nephrectomy: A Multi-institutional Analysis of 1272 Consecutive Patients.
|
Academic Article
|
Urinary miRNAs Predict Metastasis in Patients With Clinically Localized Clear Cell Renal Cell Carcinoma Treated With Nephrectomy.
|